Showing 1 - 10 of 199
Persistent link: https://www.econbiz.de/10013520463
Persistent link: https://www.econbiz.de/10013520901
, Frankreich, Italien, Schweiz, Niederlande, Spanien, Großbritannien, Australien, Kanada, USA und Japan. Insbesondere werden frei …
Persistent link: https://www.econbiz.de/10014015068
Grundlagen -- Gesamtwirtschaftliche Megatrends und die Aussicht auf dynamische Zukunftsindustrien in Japan … -- Identifikation von Zukunftstechnologien in Japan -- Finanzierung von Zukunftstechnologien in Japan -- Mensch und Gesundheit -- Life … Sciences und Biotechnologie in Japan -- Die japanische Pharmaindustrie -- Der Medizintechnikmarkt in Japan -- Miniaturisierung …
Persistent link: https://www.econbiz.de/10014014296
Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially...
Persistent link: https://www.econbiz.de/10012819089
How efficient is the Chinese healthcare system? Milcent examines the medication market in China against the global picture of healthcare organization, and how public healthcare insurance plans have been implemented in recent years, as well as reforms to tackle hospital inefficiency. Healthcare...
Persistent link: https://www.econbiz.de/10012397155
Effects of Health Communication and Pharmaceutical Advertising -- Taking Matters Global: The (Im)Possibilities of Cross-Cultural Advertising -- Consumer Self-Empowerment: Increasing Consumer Control and Choice -- Modelling Consumer Self-Empowerment -- Consumer Responses to Different Advertising...
Persistent link: https://www.econbiz.de/10014019336
Umsatzrentabilität -- Regionale Faktoren in Bezug auf die wirtschaftlichen Parameter und weitere wettbewerbliche Positionierungsabfragen der Apotheken -- Kaufkraft der Kunden -- Die Innovationsneigung der Apotheker.
Persistent link: https://www.econbiz.de/10014282804
This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example,...
Persistent link: https://www.econbiz.de/10012396287
As ‘disruption’ is currently becoming the new buzzword in boardrooms, this book advocates that the most striking opportunity for business today is making itself relevant to its stakeholders. By presenting a new route via innovative business models, a transformational corporate approach to...
Persistent link: https://www.econbiz.de/10012396539